Eligibility for Pfizer-BioNTech COVID-19 Vaccine Booster Dose Expanded
U.S. Food and Drug Administration | May 18, 2022
The FDA expanded the eligibility for the vaccine booster dose to individuals five through 11 years of age
Articles by U.S. Food and Drug Administration
FDA Approves First COVID-19 Treatment for Young Children
U.S. Food and Drug Administration | Apr 26, 2022
U.S. FDA expanded the approval of the COVID-19 treatment Veklury to include pediatric patients 28 days of age
FDA Authorizes First COVID-19 Diagnostic Test Using Breath Samples
U.S. Food and Drug Administration | Apr 19, 2022
New test provides results in less than three minutes
Meeting on COVID-19 Vaccines to Discuss Future Boosters
U.S. Food and Drug Administration | Mar 21, 2022
FDA announces a virtual meeting of its Vaccines and Related Biological Products Advisory Committee
FDA Urges Companies to Be “Recall Ready” to Protect Public Health
U.S. Food and Drug Administration | Mar 04, 2022
New guidance to help companies prepare to quickly and effectively remove violative products from the market
Authorization of COVID-19 Vaccine for Children under Five Postponed
U.S. Food and Drug Administration | Feb 14, 2022
FDA postpones authorization meeting of Pfizer-BioNTech COVID-19 vaccine for children six months through four years old
Blood Specimen Collection Tube Shortage
U.S. Food and Drug Administration | Feb 01, 2022
The FDA updates their device shortage list to include all blood specimen collection tubes
FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine
U.S. Food and Drug Administration | Jan 10, 2022
This brings consistency in the timing for administration of a booster dose among the available mRNA vaccines
FDA Authorizes First Antiviral Pill for COVID-19
U.S. Food and Drug Administration | Dec 22, 2021
In a trial, Paxlovid reduced COVID-19 related hospitalization or death by 88 percent
Test Policies Updated to Help to Ensure Accuracy, Reliability of COVID-19 Tests
U.S. Food and Drug Administration | Nov 15, 2021
FDA details test priorities and takes steps regarding the appropriate oversight of tests